Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease
Authors:
- Michael HendricksMHMichael Hendricks
- Jill A. LietzauJLJill A. Lietzau
- James M. PludaJPJames M. Pluda
- Hiroaki MitsuyaHMHiroaki Mitsuya
- Samuel BroderSBSamuel Broder
- Robert YarchoanRYRobert Yarchoan
- 1 January 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 11 (1) , 59-66
Abstract
To evaluate the effects of treatment with alternating and simultaneous regimens of zidovudine and didanosine on neuropsychological function in patients with symptomatic HIV-1 disease, focusing on patients with possible HIV-1-associated central nervous system (CNS) compromise at entry. Randomized non-blinded clinical trial. Government medical research center. Thirty-eight patients with symptomatic HIV-1 disease, of whom 21 had evidence of CNS compromise at entry. After 12 weeks of therapy, overall significant improvements in memory (P < 0.01) and focused attention (P < 0.001) were seen on both regimens. These gains, however, were largely limited to those patients with HIV-1-associated CNS compromise at entry (P < 0.05). Improvements were also noted in receptive vocabulary, reading, perceptual discrimination and reasoning, divided attention, motor strength, and in mood and affect. Improvements in those latter functions were generally of limited magnitude and were of comparable size for both compromised and non-compromised patients. There was no overall difference between the two drug regimens in the effects on CNS parameters. Therapy-related improvements were noted particularly for patients with HIV-1-associated CNS compromise. Neuropsychological functions that have been implicated in AIDS dementia--memory and attention--showed the greatest gains. In contrast to the previously described superiority of the simultaneous regimen with regard to immunologic and virologic parameters, there was no difference between the regimens with regard to CNS measures. This supports the contention that the CNS constitutes a relative independent compartment in terms of HIV disease and treatment.Keywords
This publication has 28 references indexed in Scilit:
- Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV diseaseAIDS, 1995
- Human Immunodeficiency Virus Type 1 (HIV-l) Viremia Changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV-l Infection Receiving Alternating or Simultaneous Zidovudine and Didanosine TherapyThe Journal of Infectious Diseases, 1995
- A Randomized Pilot Study of Alternating or Simultaneous Zidovudine and Didanosine Therapy in Patients with Symptomatic Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1994
- Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Journal of Clinical Investigation, 1993
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Standard scores for Wechsler memory scale subtestsJournal of Clinical Psychology, 1978
- CORRELATIONS BETWEEN THE TRAIL MAKING TEST AND THE WECHSLER-BELLEVUE SCALEPerceptual and Motor Skills, 1959